Literature DB >> 30003719

Photodynamic combinational therapy in cancer treatment.

Qianyu Zhang1, Libo Li.   

Abstract

Photodynamic therapy (PDT) has attracted widespread attention in recent years as a non-invasive and highly selective approach for cancer treatment. PDT involves the activation of a photosensitizer by an appropriate wavelength of light, generating transient levels of reactive oxygen species (ROS). However, the utilization of PDT against deep tumors has been greatly limited by insufficient luminous flux and the occurrence of peripheral tissue damage. Therefore, experts have begun to explore whether the combination of PDT with other treatments can improve its efficacy. In this review, we have collected articles about experiments (in vitro and in vivo) and clinical research on photodynamic combination therapies in recent years, roughly divided into four parts corresponding to PDT combined with chemotherapy, radiotherapy, immunotherapy and other therapies, to compare the therapeutic effects of the combination therapy and monotherapy. The results showed that photodynamic combination treatments, in general, perform better than single treatment modalities. Thus, the increased therapeutic effects, reduced side effects and coordination treatment effects of PDT are worth of further exploration.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30003719

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  18 in total

Review 1.  Potential Application of Photosensitizers With High-Z Elements for Synergic Cancer Therapy.

Authors:  Paromita Sarbadhikary; Blassan P George; Heidi Abrahamse
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

2.  Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles.

Authors:  Zeting Yuan; Guohua Fan; Honglei Wu; Chaolian Liu; Yueping Zhan; Yanyan Qiu; Chenting Shou; Feng Gao; Jun Zhang; Peihao Yin; Ke Xu
Journal:  Mol Ther       Date:  2021-05-21       Impact factor: 12.910

Review 3.  Pheophorbide a: State of the Art.

Authors:  Assunta Saide; Chiara Lauritano; Adrianna Ianora
Journal:  Mar Drugs       Date:  2020-05-14       Impact factor: 5.118

Review 4.  Pathological and Pharmacological Roles of Mitochondrial Reactive Oxygen Species in Malignant Neoplasms: Therapies Involving Chemical Compounds, Natural Products, and Photosensitizers.

Authors:  Yasuyoshi Miyata; Yuta Mukae; Junki Harada; Tsuyoshi Matsuda; Kensuke Mitsunari; Tomohiro Matsuo; Kojiro Ohba; Hideki Sakai
Journal:  Molecules       Date:  2020-11-11       Impact factor: 4.411

Review 5.  Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas.

Authors:  Jeffrey I Traylor; Mark N Pernik; Alex C Sternisha; Samuel K McBrayer; Kalil G Abdullah
Journal:  Cancers (Basel)       Date:  2021-02-02       Impact factor: 6.639

Review 6.  Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends.

Authors:  Chun-Yan Shih; Pei-Ting Wang; Wu-Chou Su; Hsisheng Teng; Wei-Lun Huang
Journal:  Biomedicines       Date:  2021-02-01

Review 7.  Mitochondrial Dynamics, ROS, and Cell Signaling: A Blended Overview.

Authors:  Valentina Brillo; Leonardo Chieregato; Luigi Leanza; Silvia Muccioli; Roberto Costa
Journal:  Life (Basel)       Date:  2021-04-10

Review 8.  Photodynamic Therapy-Current Limitations and Novel Approaches.

Authors:  Gurcan Gunaydin; M Emre Gedik; Seylan Ayan
Journal:  Front Chem       Date:  2021-06-10       Impact factor: 5.221

9.  Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.

Authors:  Daniela León; Kurt Buchegger; Ramón Silva; Ismael Riquelme; Tamara Viscarra; Bárbara Mora-Lagos; Louise Zanella; Fabiola Schafer; Cristina Kurachi; Juan Carlos Roa; Carmen Ili; Priscilla Brebi
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

10.  Anti-Biofilm Activity of the Fungal Phytotoxin Sphaeropsidin A Against Clinical Isolates of Antibiotic-Resistant Bacteria.

Authors:  Emanuela Roscetto; Marco Masi; Matilde Esposito; Roberta Di Lecce; Antonella Delicato; Lucia Maddau; Viola Calabrò; Antonio Evidente; Maria Rosaria Catania
Journal:  Toxins (Basel)       Date:  2020-07-08       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.